Molecular Imaging Biomarkers in Dementia: Amyloid and tau PET imaging aids evaluation of patients suspected of having Alzheimer disease or other dementias. | Pract Neurol (Fort Wash Pa);19(9): 34-45, 2020. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

Virtual Health Library

United States - Mexico Border

Subject descriptor lookup Advanced Search

Molecular Imaging Biomarkers in Dementia: Amyloid and tau PET imaging aids evaluation of patients suspected of having Alzheimer disease or other dementias.

Dickerson, Brad; Atri, Alireza.

Affiliation

Dickerson B; Director, Frontotemporal Disorders, Unit Department of Neurology, Massachusetts General Hospital.
Atri A; Director, Banner Sun Health Research Institute, Banner Health, Sun City, AZ.

Pract Neurol (Fort Wash Pa) ; 19(9): 34-45, 2020.

Article in En | MEDLINE | ID: mdl-34456638

Search on Google

Full text: 1 Database: MEDLINE Language: En Year: 2020 Type: Article

Search on Google

Full text: 1 Database: MEDLINE Language: En Year: 2020 Type: Article